Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dapsone, also known as 4,4'-sulfonyldianiline (SDA) or diaminodiphenyl sulfone (DDS), is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is a second-line medication for the treatment and prevention of pneumocystis pneumonia and for the prevention of toxoplasmosis in those who have poor immune…
History & Applications
Explore the main themes, entities and connections around Dapsone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
used effects also use effective may treatment combination side include methemoglobinemia leprosy drug hypersensitivity skin severe sulfone anemia mouth liver
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dapsone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dapsone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Dapsone | ATC code | D10AX05 (WHO) J04BA02 (WHO) | 1.00 | infobox |
| Dapsone | Bioavailability | 70 to 80% | 1.00 | infobox |
| Dapsone | CAS Number | 80-08-0 Y | 1.00 | infobox |
| Dapsone | ChEBI | CHEBI:4325 Y | 1.00 | infobox |
| Dapsone | ChEMBL | ChEMBL1043 Y | 1.00 | infobox |
| Dapsone | ChemSpider | 2849 Y | 1.00 | infobox |
| Dapsone | CompTox Dashboard (EPA) | DTXSID4020371 | 1.00 | infobox |
| Dapsone | DrugBank | DB00250 Y | 1.00 | infobox |
| Dapsone | ECHA InfoCard | 100.001.136 | 1.00 | infobox |
| Dapsone | Elimination half-life | 20 to 30 hours | 1.00 | infobox |
| Dapsone | Excretion | Kidney | 1.00 | infobox |
| Dapsone | Formula | C12H12N2O2S | 1.00 | infobox |
| Dapsone | KEGG | D00592 Y | 1.00 | infobox |
| Dapsone | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Dapsone | Legal status | US: ℞-only | 1.00 | infobox |
| Dapsone | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Dapsone | License data | US DailyMed: Dapsone | 1.00 | infobox |
| Dapsone | MedlinePlus | a682128 | 1.00 | infobox |
| Dapsone | Melting point | 175 to 176 °C (347 to 349 °F) | 1.00 | infobox |
| Dapsone | Metabolism | Liver (mostly CYP2E1-mediated) | 1.00 | infobox |
| Dapsone | Molar mass | 248.30 g·mol−1 | 1.00 | infobox |
| Dapsone | Protein binding | 70 to 90% | 1.00 | infobox |
| Dapsone | PubChem CID | 2955 | 1.00 | infobox |
| Dapsone | Routes of administration | By mouth, topical | 1.00 | infobox |
| Dapsone | Trade names | Aczone, others | 1.00 | infobox |
| Dapsone | UNII | 8W5C518302 | 1.00 | infobox |
| Dapsone | causes | hemolytic anemia in patients with G6PD deficiency | 0.90 | text |
| Dapsone | is a | recommended treatment for erythema elevatum diutinum | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.